The global spinal muscular atrophy (sma) treatment market size was valued at USD 2.22 billion in 2021 and is poised to grow at a significant CAGR of 28.9% during the forecast period 2022-28. SMA (spinal muscular atrophy) is a category of hereditary illnesses that causes muscle degradation and compromises muscle function. It usually causes weakness and might even result in death. Motor neurons...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian